Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,486.40
(
0.32%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,970.47
(
-0.01%
)
News Focus
News Focus
Post# of 447247
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

marjac

Send PM Follow Ignore
Followers 97
Posts 3675
Boards Moderated 0
Alias Born 11/13/2018

marjac

Member Level

Re: ramfan60 post# 422789

Tuesday, 04/02/2024 2:16:28 PM

Tuesday, April 02, 2024 2:16:28 PM

Post# of 447247
And that's just the thing. Their business model is dependent upon the Generic being prescribed for the CVD indication. An injunction which formally stops that, could cripple generic Vascepa.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News